Delta 9 Cannabis' Q1 Revenue Drops Slightly YoY, Gross Profit Grows 10%
Delta 9 Cannabis' Q1 Revenue Drops Slightly YoY, Gross Profit Grows 10%
Delta 9 Cannabis Inc. (TSX:DN) (OTC:DLTNF) announced its financial and operating results on Wednesday for the three months ending March 31, 2024.
Delta 9 Cannabis Inc.（多倫多證券交易所股票代碼：DLTNF）週三公佈了截至2024年3月31日的三個月的財務和經營業績。
"During the first quarter, we continued to focus on sustaining revenues across our core business units while optimizing our margins," said John Arbuthnot, CEO of Delta 9. "We will continue our relentless focus on cost and operational efficiencies and strengthening our balance sheet to deliver sustained, profitable growth for our shareholders."
達美9首席執行官約翰·阿布思諾特表示：“在第一季度，我們繼續專注於維持核心業務部門的收入，同時優化利潤率。”“我們將繼續堅持不懈地關注成本和運營效率，加強資產負債表，爲股東帶來持續的盈利增長。”
Do you want to learn more about investments and financial data from the cannabis industry? Don't miss the opportunity to join us at the 19th Benzinga Cannabis Capital Conference in Chicago this October 8-9. Engage with top executives, investors, policymakers, and advocates to explore the industry's future. Secure your tickets now before prices increase by following this link.
您想更多地了解大麻行業的投資和財務數據嗎？千萬不要錯過參加今年10月8日至9日在芝加哥舉行的第19屆Benzinga大麻資本會議的機會。與高層管理人員、投資者、政策制定者和倡導者互動，探索該行業的未來。點擊此鏈接，立即在價格上漲之前保護您的門票。
Q1 2024 Financial Highlights
2024 年第一季度財務摘要
- Net revenue was $CA16.5 million ($12.1 million), representing a decrease of 2%, from CA$16.9 million for the same quarter last year.
- Gross profit, before changes in the fair value of biological assets, of CA$4.7 million, representing an increase of 10% year-over-year.
- Gross profit margin, before changes in the fair value of biological assets, of 28%, versus 25% for the same quarter last year.
- Loss from operations was CA$3 million, versus a loss from operations of CA$1.2 million for the same quarter last year.
- Net loss was CA$ 4.9 million, compared to a CA$ 3.1 million net loss in the prior year's period.
- Adjusted EBITDA came in positive at CA$5,270 for the first quarter of 2024 versus an adjusted EBITDA loss of CA$475,595 for the same quarter last year.
- 淨收入爲1,650萬加元（合1,210萬美元），較去年同期的1,690萬加元下降了2％。
- 扣除生物資產公允價值變動前的毛利爲470萬加元，同比增長10％。
- 扣除生物資產公允價值變動前的毛利率爲28％，而去年同期爲25％。
- 運營虧損爲300萬加元，而去年同期的運營虧損爲120萬加元。
- 淨虧損爲490萬加元，而去年同期的淨虧損爲310萬加元。
- 2024年第一季度調整後的息稅折舊攤銷前利潤爲正數，爲5,270加元，而去年同期調整後的息稅折舊攤銷前利潤虧損爲475,595加元。
DLTNF Price Action
DLTNF 價格走勢
Delta 9's shares traded 0.29% higher at $0.0174 per share after the market close on Wednesday.
週三收盤後，達美9的股價上漲0.29％，至每股0.0174美元。
Related News
相關新聞
- Delta 9 Completes Private Placement of Common Share to Haywood
- Is Delta 9 Cannabis Inc.'s Q2 2023 Revenue Surge Enough To Offset Net Losses?
- Delta 9 Expands Distribution Business In Manitoba
- Delta 9完成向海伍德私募普通股配售
- Delta 9 Cannabis Inc. 是嗎2023 年第二季度收入激增是否足以抵消淨虧損？
- Delta 9 擴大了曼尼托巴省的分銷業務
譯文內容由第三人軟體翻譯。